Early Life Intervention in Pediatrics Supported by E-health - SMOKE
Eligible age
Up to 5 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .
Sponsor: Insel Gruppe AG, University Hospital Bern
You may qualify if…
- ✓ Age: younger than 6 years
- ✓ Exposed to second-hand smoke at home (at least one parent smoking)
- ✓ German speaking parent
- ✓ All sex and ethnic backgrounds
- ✓ Signed informed consent form from parent
- ✓ Children live/grow-up in the same household as the parental participant
- ✓ Referred by a health care professional (e.g. physician, midwife, nurse, other professions)
You may not qualify if…
- ✕ Participation in another study/trial targeting similar outcomes
- ✕ Participation in an active smoking cessation programme
Source: ClinicalTrials.gov · NCT06311162 · last updated 2026-05-06